MIM
IBB icon

MTM Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

MTM Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.78K Hold
46
– – ﹤0.01% 545
2026
Q1 		$7.8K Hold
46
– – ﹤0.01% 553
2025
Q4 		$7.79K Hold
46
– – ﹤0.01% 555
2025
Q3 		$6.65K Hold
46
– – ﹤0.01% 579
2025
Q2 		$5.83K Hold
46
– – ﹤0.01% 595
2025
Q1 		$5.73K Hold
46
– – ﹤0.01% 266
2024
Q4 		$6.08K Buy
+46
New +$6.47K ﹤0.01% 257
2024
Q2 		– Sell
-15
Closed -$2.06K – 268
2024
Q1 		$2.06K Buy
+15
New +$2.05K ﹤0.01% 277
2023
Q1 		– Sell
-28
Closed -$3.68K – 268
2022
Q4 		$3.68K Hold
28
– – ﹤0.01% 259
2022
Q3 		$3K Buy
+28
New +$3.48K ﹤0.01% 258

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

MTM Investment Management's IBB Position: Q2 2026 in Review

MTM Investment Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 46 shares worth $8.78K. The position accounts for ﹤0.01% of the portfolio, ranked #545.

MTM Investment Management first reported a position in IBB in Q3 2022 and has held it in 10 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • MTM Investment Management held 46 shares of iShares Biotechnology ETF worth $8.78K as of Q2 2026.
  • MTM Investment Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of MTM Investment Management's portfolio in Q2 2026, its #545 holding.
  • MTM Investment Management first reported a position in iShares Biotechnology ETF in Q3 2022 and has held it in 10 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on MTM Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.